Literature DB >> 3601495

Cefotaxime for treatment of gram-negative bacterial meningitis in infants and children.

T J Feldstein, D L Uden, T A Larson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3601495     DOI： 10.1097/00006454-198705000-00013

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  7 in total

Review 1.  Antibiotic treatment of suspected neonatal meningitis.

Authors:  G Gandy; J Rennie
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

Review 2.  Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis.

Authors:  K Prasad; A Kumar; P K Gupta; T Singhal
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 3.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

Review 4.  Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval.

Authors:  G L Kearns; R A Young; R F Jacobs
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

Review 5.  Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.

Authors:  R N Brogden; C M Spencer
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

Review 6.  Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.

Authors:  A Adu; C L Armour
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

7.  Treatment of childhood bacterial meningitis.

Authors:  H Lecour; A Seara; J Cordeiro; M Miranda
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.